FI3619204T3 - Yhdisteitä hengitystiesairauksien hoitoon - Google Patents

Yhdisteitä hengitystiesairauksien hoitoon

Info

Publication number
FI3619204T3
FI3619204T3 FIEP18795097.7T FI18795097T FI3619204T3 FI 3619204 T3 FI3619204 T3 FI 3619204T3 FI 18795097 T FI18795097 T FI 18795097T FI 3619204 T3 FI3619204 T3 FI 3619204T3
Authority
FI
Finland
Prior art keywords
polymorph
solvate
salt
compound
group
Prior art date
Application number
FIEP18795097.7T
Other languages
English (en)
Finnish (fi)
Inventor
Spencer Williams
Sayali Shah
Zalihe Hakki
Alastair Stewart
Original Assignee
Tianli Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017901611A external-priority patent/AU2017901611A0/en
Application filed by Tianli Biotech Pty Ltd filed Critical Tianli Biotech Pty Ltd
Application granted granted Critical
Publication of FI3619204T3 publication Critical patent/FI3619204T3/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FIEP18795097.7T 2017-05-03 2018-05-03 Yhdisteitä hengitystiesairauksien hoitoon FI3619204T3 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
FI3619204T3 true FI3619204T3 (fi) 2025-11-06

Family

ID=64015663

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP18795097.7T FI3619204T3 (fi) 2017-05-03 2018-05-03 Yhdisteitä hengitystiesairauksien hoitoon

Country Status (9)

Country Link
US (2) US20200079757A1 (cg-RX-API-DMAC7.html)
EP (1) EP3619204B1 (cg-RX-API-DMAC7.html)
JP (2) JP7788128B2 (cg-RX-API-DMAC7.html)
CN (1) CN110753688A (cg-RX-API-DMAC7.html)
AU (3) AU2018262108A1 (cg-RX-API-DMAC7.html)
ES (1) ES3049333T3 (cg-RX-API-DMAC7.html)
FI (1) FI3619204T3 (cg-RX-API-DMAC7.html)
PT (1) PT3619204T (cg-RX-API-DMAC7.html)
WO (1) WO2018201192A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016149756A1 (en) 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases
AU2019374731B2 (en) * 2018-11-07 2025-08-21 Tianli Biotech Pty Ltd Compounds and compositions for the treatment of respiratory diseases
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
JP2001526230A (ja) * 1997-12-19 2001-12-18 スミスクライン・ビーチャム・コーポレイション ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
MX2012004997A (es) * 2009-10-28 2012-06-12 Pfizer Derivados de imidazol como inhibidores de la caseina quinasa.
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
WO2016149756A1 (en) 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases

Also Published As

Publication number Publication date
JP7788128B2 (ja) 2025-12-18
JP2023134493A (ja) 2023-09-27
JP2020518621A (ja) 2020-06-25
US20200079757A1 (en) 2020-03-12
EP3619204A1 (en) 2020-03-11
PT3619204T (pt) 2025-10-29
CN110753688A (zh) 2020-02-04
AU2024200521B2 (en) 2025-10-02
EP3619204A4 (en) 2021-03-24
AU2024200521A1 (en) 2024-02-15
US20220380343A1 (en) 2022-12-01
EP3619204B1 (en) 2025-10-01
AU2018262108A1 (en) 2019-11-21
AU2022202774A1 (en) 2022-05-19
WO2018201192A1 (en) 2018-11-08
ES3049333T3 (en) 2025-12-16

Similar Documents

Publication Publication Date Title
CL2023000196A1 (es) Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y métodos de uso de los mismos
ECSP20013248A (es) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
MX2021000310A (es) Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidin-2,6-diona y su uso en el tratamiento de las enfermedades que dependen de la familia de dedo de zinc ikaros (ikzf2).
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
JOP20210001A1 (ar) مشتقات 3-(5- هيدروكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخدامها لمعالجة أمراض مرتبطة ببروتين ذات أصبع الزنك من عائلة (ikaros 2 (ikzf2
JP2019504050A5 (cg-RX-API-DMAC7.html)
EP4467549A3 (en) Intermediates of n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives
ES2655091T3 (es) Derivados del ácido pirrolidíncarboxílico como agonistas del receptor 43 acoplado a proteína G (GPR43), composición farmacéutica y métodos para su uso en el tratamiento de trastornos metabólicos
JP2016506369A5 (cg-RX-API-DMAC7.html)
AR073209A1 (es) Tienopirimidinas utiles para la profilaxis y/o tratamiento de enfermedades influenciadas por la inhibicion de quinasas mnk1 y/o mnk2 ,tales como enfermedades metabolicas y trastornos inflamatorios,y composiciones farmaceuticas que las contienen.
HRP20210847T1 (hr) Supstituirani derivati indola kao inhibitori replikacije denga virusa
IL272762B1 (en) Compressed heterocyclics as BCL-2 inhibitors for the treatment of neoplastic diseases
JP2017501237A5 (cg-RX-API-DMAC7.html)
PE20141148A1 (es) Mesilato de n-[5-(aminosulfonil)-4 metil-1-3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida monohidrato
JP2015520769A5 (cg-RX-API-DMAC7.html)
EA201590023A1 (ru) Новые 4-замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные бензимидазолами, в качестве противовирусных средств против респираторного синцитиального вируса
IL276711B1 (en) Arginase inhibitors and methods of use thereof
AR062394A1 (es) Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis
FI3546462T3 (fi) Uusi oksoisokinoliinijohdannainen
EA202190395A1 (ru) Замещенные гетероарилом сульфонамидные соединения и их применение в качестве терапевтических средств
EA201891780A1 (ru) Производные сульфонамида и содержащие их фармацевтические композиции
JP2016501185A5 (cg-RX-API-DMAC7.html)
RU2019123404A (ru) Производное пиримидина
BR112022004099A2 (pt) Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx
MX2020010866A (es) Compuestos novedosos utiles como abridores del canal de potasio.